Want to see DH full AI Analyst Report?
Definitive Healthcare Corp (DH) Ratios
Definitive Healthcare Corp Ratios
DH's free cash flow for Q2 2026 was $8.51M. For the 2026 fiscal year, DH's free cash flow was decreased by $-2.94M and operating cash flow was $11.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.64 | 2.30 | 2.23 | 2.94 | 3.61 |
| Quick Ratio | 1.64 | 2.30 | 2.23 | 2.94 | 3.61 |
| Cash Ratio | 1.04 | 0.65 | 0.77 | 1.04 | 3.15 |
| Solvency Ratio | -0.23 | -0.75 | -0.24 | 0.08 | 0.01 |
| Operating Cash Flow Ratio | 0.34 | 0.36 | 0.24 | 0.25 | 0.20 |
| Short-Term Operating Cash Flow Coverage | 6.15 | 4.23 | 3.00 | 4.14 | 3.67 |
| Net Current Asset Value | $ -98.89M | $ -112.02M | $ -246.29M | $ -226.93M | $ -173.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.23 | 0.15 | 0.13 | 0.13 |
| Debt-to-Equity Ratio | 0.61 | 0.57 | 0.31 | 0.29 | 0.31 |
| Debt-to-Capital Ratio | 0.38 | 0.36 | 0.24 | 0.23 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.36 | 0.34 | 0.22 | 0.21 | 0.23 |
| Financial Leverage Ratio | 2.62 | 2.45 | 2.12 | 2.24 | 2.43 |
| Debt Service Coverage Ratio | -6.58 | -18.36 | -7.69 | 2.22 | 0.72 |
| Interest Coverage Ratio | -1.82 | -47.91 | -21.69 | -3.93 | -1.05 |
| Debt to Market Cap | 0.54 | 0.51 | 0.23 | 0.24 | 0.10 |
| Interest Debt Per Share | 1.72 | 2.30 | 2.51 | 2.84 | 3.06 |
| Net Debt to EBITDA | -0.06 | -0.26 | -0.57 | 4.92 | -5.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.88% | 78.30% | 81.11% | 80.86% | 75.51% |
| EBIT Margin | -81.97% | -245.40% | -116.53% | -13.78% | -22.19% |
| EBITDA Margin | -58.74% | -224.92% | -95.95% | 11.78% | 13.89% |
| Operating Profit Margin | -8.52% | -281.85% | -131.18% | -19.78% | -16.44% |
| Pretax Profit Margin | -86.64% | -251.28% | -122.58% | -18.81% | -37.78% |
| Net Profit Margin | -57.52% | -163.81% | -80.50% | -3.24% | -31.24% |
| Continuous Operations Profit Margin | -82.52% | -234.51% | -115.20% | -10.86% | -37.51% |
| Net Income Per EBT | 66.39% | 65.19% | 65.67% | 17.25% | 82.70% |
| EBT Per EBIT | 1016.64% | 89.16% | 93.44% | 95.08% | 229.77% |
| Return on Assets (ROA) | -18.89% | -37.92% | -11.08% | -0.34% | -2.45% |
| Return on Equity (ROE) | -49.42% | -92.97% | -23.50% | -0.76% | -5.96% |
| Return on Capital Employed (ROCE) | -3.56% | -76.58% | -19.92% | -2.22% | -1.37% |
| Return on Invested Capital (ROIC) | -3.32% | -70.24% | -18.70% | -1.28% | -1.36% |
| Return on Tangible Assets | -47.78% | -103.75% | -47.32% | -1.62% | -10.34% |
| Earnings Yield | -45.39% | -86.18% | -18.06% | -0.65% | -1.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.65 | 4.74 | 4.24 | 3.79 | 3.83 |
| Payables Turnover | 16.20 | 5.09 | 8.20 | 10.80 | 8.75 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 13.36 | 22.30 | 17.88 | 15.74 | 32.78 |
| Asset Turnover | 0.33 | 0.23 | 0.14 | 0.10 | 0.08 |
| Working Capital Turnover Ratio | 1.56 | 1.20 | 1.04 | 0.75 | 1.12 |
| Cash Conversion Cycle | 56.02 | 5.26 | 41.53 | 62.58 | 53.48 |
| Days of Sales Outstanding | 78.55 | 77.04 | 86.02 | 96.39 | 95.20 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 22.53 | 71.78 | 44.49 | 33.81 | 41.72 |
| Operating Cycle | 78.55 | 77.04 | 86.02 | 96.39 | 95.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.50 | 0.50 | 0.37 | 0.35 | 0.26 |
| Free Cash Flow Per Share | 0.35 | 0.39 | 0.34 | 0.27 | 0.19 |
| Dividend Paid and CapEx Coverage Ratio | 2.71 | 3.33 | 2.70 | 1.68 | 1.70 |
| Capital Expenditure Coverage Ratio | 3.22 | 4.71 | 13.84 | 4.27 | 3.75 |
| Operating Cash Flow Coverage Ratio | 0.31 | 0.23 | 0.15 | 0.13 | 0.09 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.23 | 0.16 | 0.16 | 0.15 |
| Free Cash Flow Yield | 12.11% | 9.56% | 3.41% | 2.45% | 0.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.21 | -1.16 | -5.54 | -153.87 | -51.09 |
| Price-to-Sales (P/S) Ratio | 1.27 | 1.90 | 4.46 | 4.99 | 15.96 |
| Price-to-Book (P/B) Ratio | 1.09 | 1.08 | 1.30 | 1.17 | 3.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.26 | 10.46 | 29.33 | 40.78 | 143.49 |
| Price-to-Operating Cash Flow Ratio | 5.69 | 8.24 | 27.21 | 31.23 | 105.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.01 | -0.00 | 2.47 | 0.80 |
| Enterprise Value Multiple | -2.22 | -1.11 | -5.21 | 47.29 | 109.84 |
| Enterprise Value | 315.13M | 627.13M | 1.26B | 1.24B | 2.54B |
| EV to EBITDA | -2.22 | -1.11 | -5.21 | 47.29 | 109.84 |
| EV to Sales | 1.30 | 2.49 | 5.00 | 5.57 | 15.26 |
| EV to Free Cash Flow | 8.50 | 13.68 | 32.92 | 45.51 | 137.17 |
| EV to Operating Cash Flow | 5.86 | 10.78 | 30.54 | 34.86 | 100.55 |
| Tangible Book Value Per Share | -0.62 | -0.72 | -1.76 | -1.91 | -1.19 |
| Shareholders’ Equity Per Share | 2.64 | 3.81 | 7.64 | 9.38 | 8.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | 0.07 | 0.06 | 0.42 | 0.01 |
| Revenue Per Share | 2.26 | 2.16 | 2.23 | 2.20 | 1.71 |
| Net Income Per Share | -1.30 | -3.54 | -1.79 | -0.07 | -0.53 |
| Tax Burden | 0.66 | 0.65 | 0.66 | 0.17 | 0.83 |
| Interest Burden | 1.06 | 1.02 | 1.05 | 1.37 | 1.70 |
| Research & Development to Revenue | 0.14 | 0.14 | 0.17 | 0.16 | 0.11 |
| SG&A to Revenue | 0.55 | 0.53 | 0.23 | 0.23 | 0.20 |
| Stock-Based Compensation to Revenue | 0.12 | 0.15 | 0.19 | 0.16 | 0.06 |
| Income Quality | -0.27 | -0.10 | -0.20 | -1.60 | -0.40 |
Currency in USD
